Search research articles
Contact Us
Filters
Showing results (731-740 of 968) with videos related to
Page
of 97
Sort By:
Critical Reviews in Oncology/Hematology
|
June 22, 2001
Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents
D L Newton, H J Hansen, H Liu, et al.
Clinical Lymphoma
|
November 15, 2001
Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy
D E Tsai, S J Schuster, A Matthies, et al.
Arthritis Research & Therapy
|
November 6, 2010
Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
Capucine Daridon, Daniela Blassfeld, Karin Reiter, et al.
Diseases of the Colon and Rectum
|
April 1, 1980
Colonic tumorigenesis in rats with 1,2-dimethylhydrazine
P F Hagihara, K Yoneda, C R Sachatello, et al.
Cancer
|
July 18, 2000
Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma
D M Goldenberg, H Abdel-Nabi, C L Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy
Thomas M Cardillo, Habibe Karacay, David M Goldenberg, et al.
Journal of Immunological Methods
|
August 6, 1998
Carbohydrates engineered at antibody constant domains can be used for site-specific conjugation of drugs and chelates
Z Qu, R M Sharkey, H J Hansen, et al.
European Journal of Nuclear Medicine
|
January 1, 1992
Lymphoma imaging with a new technetium-99m labelled antibody, LL2
S Murthy, R M Sharkey, D M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2005
Clinical-scale radiolabeling of a humanized anticarcinoembryonic antigen monoclonal antibody, hMN-14, with residualizing 131I for use in radioimmunotherapy
Serengulam V Govindan, Gary L Griffiths, Rhona Stein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1994
Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment
W Becker, J Bair, T Behr, et al.
Page
of 97
Search research articles
Search
Showing results (731-740 of 968) with videos related to
Sort By:
Page
of 97
Critical Reviews in Oncology/Hematology
|
June 22, 2001
Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents
D L Newton, H J Hansen, H Liu, et al.
Clinical Lymphoma
|
November 15, 2001
Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy
D E Tsai, S J Schuster, A Matthies, et al.
Arthritis Research & Therapy
|
November 6, 2010
Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
Capucine Daridon, Daniela Blassfeld, Karin Reiter, et al.
Diseases of the Colon and Rectum
|
April 1, 1980
Colonic tumorigenesis in rats with 1,2-dimethylhydrazine
P F Hagihara, K Yoneda, C R Sachatello, et al.
Cancer
|
July 18, 2000
Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma
D M Goldenberg, H Abdel-Nabi, C L Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy
Thomas M Cardillo, Habibe Karacay, David M Goldenberg, et al.
Journal of Immunological Methods
|
August 6, 1998
Carbohydrates engineered at antibody constant domains can be used for site-specific conjugation of drugs and chelates
Z Qu, R M Sharkey, H J Hansen, et al.
European Journal of Nuclear Medicine
|
January 1, 1992
Lymphoma imaging with a new technetium-99m labelled antibody, LL2
S Murthy, R M Sharkey, D M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2005
Clinical-scale radiolabeling of a humanized anticarcinoembryonic antigen monoclonal antibody, hMN-14, with residualizing 131I for use in radioimmunotherapy
Serengulam V Govindan, Gary L Griffiths, Rhona Stein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1994
Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment
W Becker, J Bair, T Behr, et al.
Page
of 97